Skip to content

Multimodal Imaging in Vitreo-retinal Surgery and Macular Dystrophies

Multimodal Imaging in Vitreo-retinal Surgery and Macular Dystrophies: Biomarkers of Morpho-Functional Recovery by Artificial Intelligence

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05747144
Acronym
MICAI
Enrollment
100
Registered
2023-02-28
Start date
2021-01-15
Completion date
2025-01-16
Last updated
2024-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular Holes, Epiretinal Membrane, Retinal Detachment, Macular Dystrophies

Keywords

vitreoretinal surgery, machine learning, decisional support systems

Brief summary

The aim of the study is to identify morphological and functional biomarkers of post-operative recovery after vitreoretinal surgery, using decisional support systems (DSS), based on multimodal big-data analysis by means of machine learning techniques in daily clinical practice

Detailed description

The aim of the study is to identify morphological and functional biomarkers of post-operative recovery after vitreoretinal surgery. Identifying the biomarkers and assessing the predictivity of recovery will make it possible to highlight the categories of patients who can benefit most from surgical treatment, and to target the patient more precisely for personalised medicine and surgery. The introduction of new decisional support systems (DSS), based on multimodal big-data analysis through machine learning techniques in daily clinical practice, is providing new useful information in patient assessment for personalised surgery.

Interventions

DIAGNOSTIC_TESTBiometry

Biometric measurements performed with IOL Master, if executable Contact or immersion echobiometry if IOL Master cannot be performed

DIAGNOSTIC_TESTRetinography (Color) + Autofluorescence (AF)

Colour + AF: EIDON, if available (60° not modulable) Colour: COBRA (60° non-modifiable) AF: Spectralis-Heidelberg (choose 55°) Other if available (choose posterior pole examination between 50-60°)

DIAGNOSTIC_TESTOCT B-scan and OCT angiography (OCTA)

OCT B-scan: 2 scans (6 mm) 1 cross line OCTA: 3x3 mm + 6x6 mm centred on the fovea 4.5 mm centred on the optic nerve

DIAGNOSTIC_TESTMicroperimetry

1\) fixation pattern 2) retinal sensitivity map

DIAGNOSTIC_TESTElectrophysiological exams

Layer-by-layer assessment of the retina using focal ERG and pattern ERG according to standardised and published methods , For patients with visus \< 3/10 and unstable fixation a protocol based on component analysis of the photopic ERG from diffuse flash will be used.

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Months to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients to undergo vitreo-retinal surgery for: 1. Macular hole 2. Epiretinal membranes 3. Retinal detachment 4. Macular dystrophies (retinal pre-prosthesis)

Exclusion criteria

* Patients under 18 years of age will be excluded; patients in whom morphological examinations cannot be performed due to poor cooperation or opacity of the dioptric media (e.g. corneal pathology). Quality of morphological images inadequate for post acquisition processing (\<6/10).

Design outcomes

Primary

MeasureTime frameDescription
Predictivity of morphological-functional radiomic data3 yearsRate of predictivity of morphological-functional radiomic data to establish the grade of recovery in the post-operative period by means of an artificial intelligence (AI) machine learning model.

Secondary

MeasureTime frameDescription
Identify predictive differences according to diagnosis3 yearsSubdivision into subgroups in order to identify predictive differences according to diagnosis
Correlating with the age of patients3 yearsIdentify predictive differences according to diagnosis and correlate them with the age of patients
Correlate with age of onset of disease3 yearsIdentify predictive differences according to diagnosis and correlate them with the age of onset of disease

Countries

Italy

Contacts

Primary ContactMaria Cristina Savastano, MD,PhD
mariacristina.savastano@unicatt.it+39 3384443002
Backup ContactAlfonso Savastano, MD,PhD
alfonso.savastano@policlinicogemelli.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026